Analysis of Early Treatment Discontinuations in Hepatitis C (HCV) Triple Therapy Era

被引：0
|
作者：
Shnitser, Anastasia
Chan, Doris H.
Herrine, Steven
Fenkel, Jonathan M.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S981 / S981
页数：1
相关论文
共 50 条
  • [31] The New Era of Hepatitis C Virus Therapy
    Al-Judaibi, Bandar
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06): : 345 - 354
  • [32] A New Era of Hepatitis C Therapy Begins
    Jensen, Donald M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13): : 1272 - 1274
  • [33] Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis
    Watkins-Riedel, T
    Ferenci, P
    Steindl-Munda, P
    Gschwantler, M
    Mueller, C
    Woegerbauer, M
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (12) : 1754 - 1760
  • [34] Early and End of Treatment Virologic Responses in Patients with Hepatitis C (HCV)genotype I Recurrence After Liver Transplant Treated with Triple Therapy using Telaprevir: A Single Center Experience
    Mantry, Parvez S.
    Wu, Chunxia
    Weinstein, Jeffrey S.
    Mubarak, Abdullah
    Nazario, Hector E.
    Madani, Bahar
    Mejia, Alejandro
    Anthony, Tiffany
    Cheng, Stephen
    HEPATOLOGY, 2012, 56 : 533A - 533A
  • [35] Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
    Blazquez-Perez, Antonio
    San Miguel, Ramon
    Mar, Javier
    PHARMACOECONOMICS, 2013, 31 (10) : 919 - 931
  • [36] Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
    Antonio Blázquez-Pérez
    Ramón San Miguel
    Javier Mar
    PharmacoEconomics, 2013, 31 : 919 - 931
  • [37] ANALYSIS OF TREATMENT OF HEPATITIS C VIRUS IN HIV/HCV CO-INFECTION
    Fayyaz, Iqra
    Anzar, Atifa
    Jamil, Maryam
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 12597 - 12600
  • [38] RENAL FUNCTION ANALYSIS IN PATIENTS RECEIVING TREATMENT FOR HEPATITIS C VIRUS (HCV)
    Pizarro Sanchez, Soledad
    Casanova Cabral, Michelle
    Menendez Maldonado, Saray
    Gracia Iguacel, Carolina
    Esteras Rubio, Raquel
    Carlos Porres, Juan
    Egido de los Rios, Jesus
    Polo Lorduy, Benjamin
    Gonzalez Parra, Emilio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1450 - 1450
  • [39] The Added Role of Pharmaceutical Intervention on Hepatitis C Virus (HCV) Treatment in the DAA Era: A Single Center Observational Prospective Cohort Analysis
    Vieira, Catarina L.
    Gaspar, Ana
    Barradas, Vania
    Dimas, Francisca
    GASTROENTEROLOGY, 2016, 150 (04) : S924 - S924
  • [40] Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era
    Wansom, Tanyaporn
    Falade-Nwulia, Oluwaseun
    Sutcliffe, Catherine G.
    Mehta, Shruti H.
    Moore, Richard D.
    Thomas, David L.
    Sulkowski, Mark S.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
12345